D. López de Castilla

Remdesivir for the Treatment of Covid-19 — Final Report

L. Dodd, R. Paredes, H. Lane, 2020, The New England journal of medicine.

Tuberculosis following solid organ transplantation

D. López de Castilla, N. Schluger, Neil W. Schluger, 2010, Transplant infectious disease : an official journal of the Transplantation Society.

Predictors of CD4+ cell count response and of adverse outcome among HIV-infected patients receiving highly active antiretroviral therapy in a public hospital in Peru.

David Iglesias, E. Gotuzzo, C. Seas, 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

Michael R. Wierzbicki, Tom M. Conrad, Cameron R. Wolfe, 2021, The Lancet Respiratory Medicine.

[Intestinal parasitosis in patients with HIV-AIDS].

E. Gotuzzo, D. López de Castilla, A. Terashima, 2006, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.

Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial

Cameron R. Wolfe, G. E. Potter, R. Davey, 2022, Annals of Internal Medicine.